Patel Sanj K sold KNSA

October 30, 2026 · Form 4 insider transaction

Patel Sanj K sold 18,685 shares of Kiniksa Pharmaceuticals International, plc at $92.77 per share, a transaction worth $1.73M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Disposed (sell-side)
Shares
18,685
Price
$92.77
Total value
$1.73M
RoleOfficer, Director
SecurityClass A Ordinary Share
Transaction codeS: Open-market sale
Transaction dateOctober 30, 2026
Filing dateNovember 3, 2026
Shares owned after939,470
OwnershipIndirect
10b5-1 planNo
AmendedNo

Footnotes

This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on July 30, 2026.; This transaction was executed in multiple trades through a broker-dealer at prices ranging between $92.26 and $93.25. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

View the original Form 4 on SEC EDGAR